Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
F
Frits Vanrhee
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2012)
4 h-index
11 pubs
347 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Frits Vanrhee's research focuses on hematological malignancies, particularly multiple myeloma, and associated treatment outcomes. His work has investigated infection risks in patients undergoing stem cell transplantation, including studies on bacteremias and the impact of specific therapies like daratumumab. Vanrhee has also explored the safety and effectiveness of various treatment regimens for multiple myeloma, such as Total Therapy trials and the use of thalidomide. His research extends to the characterization of immune cells, such as natural killer cells, for potential clinical applications. Vanrhee's publication record includes studies on bacterial infections, respiratory virus outbreaks in cancer units, and preliminary results of novel antibody therapies. He has a scholarly output reflected in an h-index of 4, with 11 total publications and 345 citations.
Metrics
- h-index: 4
- Publications: 11
- Citations: 347
Selected Publications
-
MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma (2026)
-
POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma (2026)
-
CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients (2024)
-
Infection Risk Associated with Daratumumab (2017)
-
An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations (2016)
-
Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? (2012)
-
CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb) - Preliminary Results of Subjects with Castleman’s Disease from a Phase 1 Study in Selected Hematological Malignancies. (2006)
Collaboration Network
Top Collaborators
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
5 shared publications
In database
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
Maurizio Zangari
University of Arkansas for Medical Sciences
3 shared publications
In database
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
Carolina Schinke
University of Arkansas for Medical Sciences
3 shared publications
In database
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
- CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients
Atul Kothari
University of Arkansas for Medical Sciences
2 shared publications
In database
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Mary Jo Burgess
University of Arkansas for Medical Sciences (US)
2 shared publications
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Juan Carlos Rico Crescencio
University of Arkansas for Medical Sciences
2 shared publications
In database
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Sandra P. Susanibar-Adaniya
University of Arkansas for Medical Sciences (US)
2 shared publications
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Faith E. Davies
University of Arkansas for Medical Sciences (US)
2 shared publications
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Gareth John Morgan
University of Arkansas for Medical Sciences (US)
2 shared publications
- Infection Risk Associated with Daratumumab
- An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations
Anushareddy Muddasani
University of Arkansas for Medical Sciences
2 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
Maurizio Zangari
University of Arkansas for Medical Sciences
2 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
Carolina Schinke
University of Arkansas for Medical Sciences
2 shared publications
In database
- POSTER: MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
- MM-226: Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma
Saad Z. Usmani
University of Arkansas for Medical Sciences (US)
1 shared publication
- Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?
John Crowley
Cancer Research And Biostatistics (US)
1 shared publication
- Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?
Antje Hoering
Cancer Research And Biostatistics (US)
1 shared publication
- Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?
Similar Researchers
Based on overlapping research topics
Md Shadiqul Hoque
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Medhavi Honhar
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Immunotherapy and Immune Responses
Amisha Fnu
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
O. Makhoul
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Hematopoietic Stem Cell Transplantation
Cancer Treatment and Pharmacology
Amanda Michelle Buck
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Microbial infections and disease research
Cancer Treatment and Pharmacology